Amneal Pharmaceuticals Inc Class A (AMRX)
EBITDA Growth
9.53%
Quarterly · Period ending:
AMRX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported9.53%period ending
Latest reported9.53%period ending
AMRX Quarterly EBITDA YoY % (12.80% → 9.53%)
Year-over-year change
High-resolution chart · PNG
AMRX ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 9.5266% | |
| 20.3624% | |
| 42.8778% | |
| -20.1801% | |
| 24.8624% | |
| 238.1916% | |
| 240.6208% | |
| 6.7314% | |
| 2.9558% | |
| -53.3767% | |
| -67.1211% | |
| 23.4444% | |
| 200.1572% | |
| 20.6946% | |
| 27.414% | |
| 14.7348% | |
| -209.5833% | |
| -22.1482% | |
| -11.3684% | |
| 27.8836% | |
| 71.814% | |
| -6.2771% | |
| 146.8865% | |
| -40.608% | |
| 90.2333% | |
| 371.3217% | |
| -52.3324% | |
| -5.3257% | |
| 121.1889% | |
| -148.0232% | |
| -34.3273% | |
| 79.9581% | |
| -366.8091% | |
| 60.216% | |
| 12.7976% |